Postoperative dysesthesia in minimally invasive transforaminal lumbar interbody fusion: a report of five cases

被引:10
|
作者
Wang, Honggang [1 ]
Zhou, Yue [1 ]
Zhang, Zhengfeng [1 ]
机构
[1] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, 183 Xinqiao St, Chongqing 400037, Peoples R China
关键词
Dysesthesia; Dorsal root ganglion; Minimally invasive spine surgery; Transforaminal lumbar interbody fusion; SURGICAL TECHNIQUE; CLINICAL-OUTCOMES; FOLLOW-UP; COMPLICATIONS; METAANALYSIS; INSTABILITY; DISKECTOMY; MANAGEMENT; INFECTION; ETIOLOGY;
D O I
10.1007/s00586-015-4365-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective Minimally invasive transforaminal lumbar interbody fusion (misTLIF) can potentially lead to dorsal root ganglion (DRG) injury which may cause postoperative dysesthesia (POD). The purpose of retrospective study was to describe the uncommon complication of POD in misTLIF. Methods Between January 2010 and December 2014, 539 patients were treated with misTLIF in investigator group. POD was defined as dysesthetic pain or burning dysesthesia at a proper DRG innervated region, whether spontaneous or evoked. Non-steroidal antiinflammatory drugs, central non-opioid analgesic agent, neuropathic pain drugs and/or intervertebral foramen block were selectively used to treat POD. Results There were five cases of POD (5/539, 0.9 %), which consisted of one patient in recurrent lumbar disc herniation (1/36, 3 %), one patient in far lateral lumbar disc herniation (1/34, 3 %), and 3 patients in lumbar spondylolisthesis (3/201, 1 %). Two DRG injury cases were confirmed by revision surgery. After the treatment by drugs administration plus DRG block, all patients presented pain relief with duration from 22 to 50 days. A gradual pain moving to distal end of a proper DRG innervated region was found as the beginning of end. Conclusions Although POD is a unique and rare complication and maybe misdiagnosed as nerve root injury in misTLIF, combination drug therapy and DRG block have an effective result of pain relief. The appearance of a gradual pain moving to distal end of a proper DRG innervated region during recovery may be used as a sign for the good prognosis.
引用
收藏
页码:1595 / 1600
页数:6
相关论文
共 50 条
  • [41] Comparison of the Outcomes of Minimally Invasive Transforaminal Lumbar Interbody Fusion and Endoscopic Transforaminal Lumbar Interbody Fusion for Lumbar Diseases: A Matched Case-Control
    Shi, Liang
    Ding, Tao
    Shi, Yihua
    Wang, Fang
    Wu, Chengcong
    WORLD NEUROSURGERY, 2022, 167 : E1231 - E1240
  • [42] The Effect of Preoperative Symptom Duration on Postoperative Outcomes After Minimally Invasive Transforaminal Lumbar Interbody Fusion
    Yoo, Joon S.
    Patel, Dillon S.
    Hrynewycz, Nadia M.
    Brundage, Thomas S.
    Mogilevsky, Franchesca A.
    Singh, Kern
    CLINICAL SPINE SURGERY, 2020, 33 (06): : E263 - E268
  • [43] Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion: Technique Note and Comparison of Early Outcomes with Minimally Invasive Transforaminal Lumbar Interbody Fusion for Lumbar Spondylolisthesis
    Zhang, Hao
    Zhou, Chuanli
    Wang, Chao
    Zhu, Kai
    Tu, Qihao
    Kong, Meng
    Zhao, Chong
    Ma, Xuexiao
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 549 - 558
  • [44] The identification of risk factors for increased postoperative pain following minimally invasive transforaminal lumbar interbody fusion
    Nathaniel W. Jenkins
    James M. Parrish
    Benjamin C. Mayo
    Nadia M. Hrynewycz
    Thomas S. Brundage
    Franchesca A. Mogilevsky
    Joon S. Yoo
    Kern Singh
    European Spine Journal, 2020, 29 : 1304 - 1310
  • [45] The Utility of Routinely Obtaining Postoperative Laboratory Studies Following a Minimally Invasive Transforaminal Lumbar Interbody Fusion
    Ahn, Junyoung
    Massel, Dustin H.
    Mayo, Benjamin C.
    Hijji, Fady Y.
    Narain, Ankur S.
    Aboushaala, Khaled
    Bohl, Daniel D.
    Elboghdady, Islam M.
    DiBattista, Jacob V.
    Singh, Kern
    CLINICAL SPINE SURGERY, 2017, 30 (10): : E1405 - E1410
  • [46] The identification of risk factors for increased postoperative pain following minimally invasive transforaminal lumbar interbody fusion
    Jenkins, Nathaniel W.
    Parrish, James M.
    Mayo, Benjamin C.
    Hrynewycz, Nadia M.
    Brundage, Thomas S.
    Mogilevsky, Franchesca A.
    Yoo, Joon S.
    Singh, Kern
    EUROPEAN SPINE JOURNAL, 2020, 29 (06) : 1304 - 1310
  • [47] Comparison between Oblique Lumbar Interbody Fusion (OLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion (MISTLIF) for Lumbar Spondylolisthesis
    Chandra, Vemula V. R.
    Prasad, Bodapati C. M.
    Hanu, Tammireddy G.
    Kale, Pavan G.
    NEUROLOGY INDIA, 2022, 70 (01) : 127 - 134
  • [48] Application and thinking of minimally invasive transforaminal lumbar interbody fusion in degenerative lumbar diseases
    Gu, Shao
    Li, Haifeng
    Wang, Daxing
    Dai, Xuejun
    Liu, Chengwei
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (06)
  • [49] Minimally Invasive Transforaminal Lumbar Interbody Fusion and Unilateral Fixation for Degenerative Lumbar Disease
    Wang, Hui-wang
    Hu, Yong-cheng
    Wu, Zhan-yong
    Wu, Hua-rong
    Wu, Chun-fu
    Zhang, Lian-suo
    Xu, Wei-kun
    Fan, Hui-long
    Cai, Jin-sheng
    Ma, Jian-qing
    ORTHOPAEDIC SURGERY, 2017, 9 (03) : 277 - 283
  • [50] Comparison of hidden blood loss and clinical efficacy of percutaneous endoscopic transforaminal lumbar interbody fusion and minimally invasive transforaminal lumbar interbody fusion
    Meng Ge
    Yuan Zhang
    Hang Ying
    Chenchen Feng
    Yanlei Li
    Jinlong Tian
    Tingxiao Zhao
    Haiyu Shao
    Yazeng Huang
    International Orthopaedics, 2022, 46 : 2063 - 2070